You are here

efruxifermin

Akero’s NASH drug combined with Ozempic cut liver fat in small study

Akero’s NASH drug combined with Ozempic cut liver fat in small study

Stat

Akero Therapeutics

Flag link:

Akero hits endpoints in midphase NASH trial, linking candidate to improvements in fibrosis

Akero hits endpoints in midphase NASH trial, linking candidate to improvements in fibrosis

Fierce Biotech

Akero Therapeuticsw

clinical trials

Flag link:

Analysts hail Akero's midphase NASH data as best in class

Analysts hail Akero's midphase NASH data as best in class

Fierce Biotech

Akero Therapeutics

clinical trials

Flag link: